Alfred Herbert (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 1:45 pm

Quick Insight

Alfred Herbert (India) Ltd's current share price of ₹3,139 seems richly valued with a P/E ratio of 38.1, indicating investor optimism. However, the company's low ROE and ROCE of 5.22% and 5.86% respectively raise concerns about its ability to generate returns for shareholders. With an OPM of 7.14% and net profit margin of 6.35%, operational efficiency appears modest. The high promoter holding of 73.87% signifies confidence from insiders, but the negligible DII ownership at 0.01% may deter institutional investor interest. The healthy ICR of 577.08x provides a cushion for debt obligations. Overall, while the market cap stands at 242 Cr., the intrinsic value assessment should consider these metrics comprehensively before making investment decisions.

Competitors of Alfred Herbert (India) Ltd

All Competitor Stocks of Alfred Herbert (India) Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:05 am

Below is a detailed analysis of the quarterly data for Alfred Herbert (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 0.70 Cr.. The value appears to be declining and may need further review. It has decreased from 8.43 Cr. (Dec 2024) to 0.70 Cr., marking a decrease of 7.73 Cr..
• For Expenses, as of Mar 2025, the value is 0.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.07 Cr. (Dec 2024) to 0.65 Cr., marking a decrease of 0.42 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 7.36 Cr. (Dec 2024) to 0.05 Cr., marking a decrease of 7.31 Cr..
• For OPM %, as of Mar 2025, the value is 7.14%. The value appears to be declining and may need further review. It has decreased from 87.31% (Dec 2024) to 7.14%, marking a decrease of 80.17%.
• For Other Income, as of Mar 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 0.02 Cr., marking an increase of 0.02 Cr..
• For Interest, as of Mar 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Dec 2024) to 0.01 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Dec 2024) to 0.22 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 7.13 Cr. (Dec 2024) to -0.16 Cr., marking a decrease of 7.29 Cr..
• For Tax %, as of Mar 2025, the value is -118.75%. The value appears to be improving (decreasing) as expected. It has decreased from 6.59% (Dec 2024) to -118.75%, marking a decrease of 125.34%.
• For Net Profit, as of Mar 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 6.67 Cr. (Dec 2024) to 0.04 Cr., marking a decrease of 6.63 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.52. The value appears to be declining and may need further review. It has decreased from 86.47 (Dec 2024) to 0.52, marking a decrease of 85.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:05 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 3:15 pm

Below is a detailed analysis of the balance sheet data for Alfred Herbert (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 0.77 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.77 Cr..
• For Reserves, as of Mar 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2024) to 122.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 131.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2024) to 131.00 Cr., marking an increase of 3.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 34.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 36.00 Cr..
• For Investments, as of Mar 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2024) to 82.00 Cr., marking a decrease of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 9.00 Cr..
• For Total Assets, as of Mar 2025, the value is 131.00 Cr.. The value appears strong and on an upward trend. It has increased from 128.00 Cr. (Mar 2024) to 131.00 Cr., marking an increase of 3.00 Cr..

Notably, the Reserves (122.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Alfred Herbert (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 82.28. This value is within the healthy range. It has increased from 8.75 (Mar 24) to 82.28, marking an increase of 73.53.
• For Diluted EPS (Rs.), as of Mar 25, the value is 82.28. This value is within the healthy range. It has increased from 8.75 (Mar 24) to 82.28, marking an increase of 73.53.
• For Cash EPS (Rs.), as of Mar 25, the value is 92.36. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 92.36, marking an increase of 81.36.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,588.12. It has increased from 1,563.84 (Mar 24) to 1,588.12, marking an increase of 24.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,588.12. It has increased from 1,563.84 (Mar 24) to 1,588.12, marking an increase of 24.28.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 135.28. It has increased from 23.25 (Mar 24) to 135.28, marking an increase of 112.03.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 102.49. This value is within the healthy range. It has increased from 9.40 (Mar 24) to 102.49, marking an increase of 93.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 92.41. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 92.41, marking an increase of 85.26.
• For PBT / Share (Rs.), as of Mar 25, the value is 92.23. This value is within the healthy range. It has increased from 6.67 (Mar 24) to 92.23, marking an increase of 85.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 82.28. This value is within the healthy range. It has increased from 8.75 (Mar 24) to 82.28, marking an increase of 73.53.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 82.28. This value is within the healthy range. It has increased from 8.75 (Mar 24) to 82.28, marking an increase of 73.53.
• For PBDIT Margin (%), as of Mar 25, the value is 75.75. This value is within the healthy range. It has increased from 40.42 (Mar 24) to 75.75, marking an increase of 35.33.
• For PBIT Margin (%), as of Mar 25, the value is 68.30. This value exceeds the healthy maximum of 20. It has increased from 30.73 (Mar 24) to 68.30, marking an increase of 37.57.
• For PBT Margin (%), as of Mar 25, the value is 68.17. This value is within the healthy range. It has increased from 28.66 (Mar 24) to 68.17, marking an increase of 39.51.
• For Net Profit Margin (%), as of Mar 25, the value is 60.82. This value exceeds the healthy maximum of 10. It has increased from 37.61 (Mar 24) to 60.82, marking an increase of 23.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 60.82. This value exceeds the healthy maximum of 20. It has increased from 37.61 (Mar 24) to 60.82, marking an increase of 23.21.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.18. This value is below the healthy minimum of 15. It has increased from 0.55 (Mar 24) to 5.18, marking an increase of 4.63.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.46. This value is below the healthy minimum of 10. It has increased from 0.43 (Mar 24) to 5.46, marking an increase of 5.03.
• For Return On Assets (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 5. It has increased from 0.52 (Mar 24) to 4.85, marking an increase of 4.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.08. It has increased from 0.01 (Mar 24) to 0.08, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 267.35. This value exceeds the healthy maximum of 3. It has increased from 245.73 (Mar 24) to 267.35, marking an increase of 21.62.
• For Quick Ratio (X), as of Mar 25, the value is 267.35. This value exceeds the healthy maximum of 2. It has increased from 245.68 (Mar 24) to 267.35, marking an increase of 21.67.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 40.01 (Mar 24) to 0.00, marking a decrease of 40.01.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 31.81 (Mar 24) to 0.00, marking a decrease of 31.81.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 59.99 (Mar 24) to 0.00, marking a decrease of 59.99.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 68.19 (Mar 24) to 0.00, marking a decrease of 68.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 577.08. This value is within the healthy range. It has increased from 19.60 (Mar 24) to 577.08, marking an increase of 557.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 464.30. This value is within the healthy range. It has increased from 19.24 (Mar 24) to 464.30, marking an increase of 445.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 148.50. It has increased from 111.69 (Mar 24) to 148.50, marking an increase of 36.81.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 14.23. This value exceeds the healthy maximum of 3. It has decreased from 62.26 (Mar 24) to 14.23, marking a decrease of 48.03.
• For EV / EBITDA (X), as of Mar 25, the value is 18.78. This value exceeds the healthy maximum of 15. It has decreased from 154.01 (Mar 24) to 18.78, marking a decrease of 135.23.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 15.15. This value exceeds the healthy maximum of 3. It has decreased from 63.00 (Mar 24) to 15.15, marking a decrease of 47.85.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 59.98 (Mar 24) to 0.00, marking a decrease of 59.98.
• For Price / BV (X), as of Mar 25, the value is 1.29. This value is within the healthy range. It has increased from 0.93 (Mar 24) to 1.29, marking an increase of 0.36.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 15.15. This value exceeds the healthy maximum of 3. It has decreased from 63.00 (Mar 24) to 15.15, marking a decrease of 47.85.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness